PAPER Reiss AB, Montufar N, DeLeon J, Pinkhasov A, Gomolin IH, Glass AD, Arain HA, Stecker MM

Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans.

Neurologist. 2021 Mar 4;26(2):52-61. PubMed: 33646990

PAPER Dutt S, Li Y, Mather M, Nation DA, Alzheimer’s Disease Neuroimaging Initiative

Brainstem substructures and cognition in prodromal Alzheimer's disease.

Brain Imaging Behav. 2021 Mar 1; PubMed: 33646514

PAPER Monllor P, Giraldo E, Badia MC, de la Asuncion JG, Alonso MD, Lloret A, Vina J

Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease.

J Alzheimers Dis. 2021 Feb 20; PubMed: 33646167

PAPER Nagaraj S, Duong TQ

Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.

J Alzheimers Dis. 2021 Feb 20; PubMed: 33646166

PAPER Merighi S, Battistello E, Casetta I, Gragnaniello D, Poloni TE, Medici V, Cirrincione A, Varani K, Vincenzi F, Borea PA, Gessi S

Upregulation of Cortical A2A Adenosine Receptors is Reflected in Platelets of Patients with Alzheimer's Disease.

J Alzheimers Dis. 2021 Feb 23; PubMed: 33646165

PAPER Arlati S, Di Santo SG, Franchini F, Mondellini M, Filiputti B, Luchi M, Ratto F, Ferrigno G, Sacco M, Greci L

Acceptance and Usability of Immersive Virtual Reality in Older Adults with Objective and Subjective Cognitive Decline.

J Alzheimers Dis. 2021 Feb 19; PubMed: 33646164

PAPER Wright CB, DeRosa JT, Moon MP, Strobino K, DeCarli C, Cheung YK, Assuras S, Levin B, Stern Y, Sun X, Rundek T, Elkind MS, Sacco RL

Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.

J Alzheimers Dis. 2021 Feb 25; PubMed: 33646162

PAPER Zhang G, Zhang Y, Shen Y, Wang Y, Zhao M, Sun L

The Potential Role of Ferroptosis in Alzheimer's Disease.

J Alzheimers Dis. 2021 Feb 19; PubMed: 33646161

PAPER Chapman S, Sunderaraman P, Joyce JL, Azar M, Colvin LE, Barker MS, McKeague I, Kreisl WC, Cosentino S

Optimizing Subjective Cognitive Decline to Detect Early Cognitive Dysfunction.

J Alzheimers Dis. 2021 Feb 26; PubMed: 33646159

PAPER Shiner T, Mirelman A, Rosenblum Y, Kavé G, Weisz MG, Bar-Shira A, Goldstein O, Thaler A, Gurevich T, Orr-Urtreger A, Giladi N, Bregman N

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews.

J Alzheimers Dis. 2021 Feb 25; PubMed: 33646158

PAPER Li B, Bi J, Wei C, Sha F

Specific Activities and the Trajectories of Cognitive Decline Among Middle-Aged and Older Adults: A Five-Year Longitudinal Cohort Study.

J Alzheimers Dis. 2021 Feb 20; PubMed: 33646157

PAPER Hinteregger B, Loeffler T, Flunkert S, Neddens J, Bayer TA, Madl T, Hutter-Paier B

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.

J Alzheimers Dis. 2021 Feb 25; PubMed: 33646155

PAPER Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL

Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.

J Alzheimers Dis. 2021 Feb 25; PubMed: 33646154

PAPER Piers RJ, Liu Y, Ang TF, Tao Q, Au R, Qiu WQ

Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

J Alzheimers Dis. 2021 Feb 26; PubMed: 33646152

PAPER Liu X, Chen X, Zhou X, Shang Y, Xu F, Zhang J, He J, Zhao F, Du B, Wang X, Zhang Q, Zhang W, Bergeron MF, Ding T, Wesson Ashford J, Zhong L

Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort.

J Alzheimers Dis. 2021 Feb 24; PubMed: 33646151